When the pharmaceutical industry started to research vaccines to fight COVID-19 in the spring of 2020, the concern that global manufacturing and packaging capacities would need to be increased arose almost simultaneously. At Catalent Pharma Solutions, a leading development and manufacturing partner to pharmaceutical companies, preparations began to boost vaccine production capabilities.

CSPE reduces the time span between designing the system and the start of production. After numerous turnkey projects involving the use of the turbo booster, Gerhard Breu, Chairman of the Optima Pharma Division, takes stock and gives an insight into how CSPE will become even more effective in the future.

A new design for isolator technology: Metall+Plastic's INTISO is distinguished by the absence of an HVAC unit and the relocation of cooling and ventilation units from the mechanical floor to the isolator plenum. Even its modular construction is innovative. This article shows the advantages and practical application scenarios that result from this.

The French pharmaceutical company Servier is expanding its business model. As it moves towards becoming a recognized player in oncology, as part of its BIO-S strategy it is investing in production capacities for biologics and small molecules. The greatest degree of flexibility possible is ensured by a MultiUse line that can fill injectable solutions into syringes and vials.